CELL INTELLIGENCE · 肿瘤细胞治疗研究

更正：下一代 CAR-NK 细胞疗法：癌症免疫治疗中的工程策略、转化挑战与未来展望

Correction: Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy.

异基因移植后急性髓系白血病复发中重编程失败的移植物抗白血病免疫的研究进展

Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.

CREM-IL-15 轴：解码 NK 细胞免疫治疗中的持久性-耗竭悖论

The CREM-IL-15 axis: decoding the persistence-exhaustion paradox in NK cell immunotherapy.

抗 BCMA-CAR-IL15 NK 细胞阻止多发性骨髓瘤在骨髓中生长但随后出现髓外疾病

Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary disease.

上皮性卵巢癌中 NK 细胞的可塑性及其治疗意义

Natural Killer Cell Plasticity in Epithelial Ovarian Cancer and Their Therapeutic Implications.

增强 CAR-NK 持久性以释放其全部治疗潜力

Enhancing CAR-NK persistence to unlock its full therapeutic potentials.

GITRL 共表达赋予抗 CD19 CAR-NK 细胞对调节性 T 细胞介导免疫抑制的抵抗

Coexpression of GITRL confers resistance to Treg cell-mediated immunosuppression to anti-CD19 CAR-NK cells.

这些数据将 CAR19-GITRL-NK 细胞定位为一种有效的创新策略，将直接肿瘤靶向与主动破坏 Treg 驱动的免疫抑制结合起来，用于治疗 B 细胞白血病和淋巴瘤。

多发性骨髓瘤中的 CAR-NK 细胞治疗：从临床前与临床图景到合力优化治疗策略

CAR-NK cell therapy in multiple myeloma: from preclinical and clinical landscape to joining the force for treatment strategies optimization.

下一代 CAR-NK 细胞治疗：工程化策略、转化挑战与肿瘤免疫治疗的未来展望

Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy.

CD47/SIRPα 免疫检查点调控：下一代 CAR 治疗的协同策略

CD47/SIRPα Immune Checkpoint Modulation: A Synergistic Strategy for Next-Generation CAR Therapies.